VRTX
Vertex Pharmaceuticals
PEG ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: VRTX
- PEG Ratio
VRTX currently shows a PEG ratio reading of 1.39 as of Aug 21, 2026. Dividing the 31.62 PE ratio by the 22.7% earnings growth rate produces this figure. When compared to the trailing 4-quarter average of 0.34, VRTX's PEG ratio reflects a 306% increase.
VRTX PEG ratio history
A ten years lookback reveals an average PEG ratio of 1.24 for Vertex Pharmaceuticals. Compared to historical data, VRTX's 1.39 PEG ratio represents an increase of 12%. The ten years high came in the Mar 2018 quarter at 7.76, reflecting peak valuation relative to growth. The bottom was reached in the Dec 2018 quarter at 0.03, suggesting attractive value relative to growth during that period.
Vertex Pharmaceuticals PEG ratio by year
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 0.03 | 29.32 | 843.3% |
| 2024 | N/A | N/A | -114.8% |
| 2023 | 3.49 | 28.96 | 8.3% |
| 2022 | 0.52 | 22.27 | 42.7% |
| 2021 | N/A | 24.16 | -12.9% |
| 2020 | 0.18 | 22.64 | 127.9% |
| 2019 | N/A | 47.81 | -44.4% |
| 2018 | 0.03 | 20.11 | 677.4% |
| 2017 | 0.43 | 141.38 | 330.4% |
| 2016 | N/A | N/A | 80.1% |
| 2015 | N/A | N/A | 26.4% |
| 2014 | N/A | N/A | -58.6% |
| 2013 | N/A | N/A | -296% |
| 2012 | N/A | N/A | -457.1% |
| 2011 | 2.29 | 237.21 | 103.7% |
Vertex Pharmaceuticals PEG ratio by quarter (TTM)
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Jun 2026 | 1.26 | 28.66 | 22.7% |
| Mar 2026 | 0.05 | 26.25 | 545.3% |
| Dec 2025 | 0.03 | 29.32 | 843.3% |
| Sep 2025 | 0.03 | 27.37 | 873.5% |
| Jun 2025 | 0.04 | 31.53 | 847.1% |
| Mar 2025 | N/A | N/A | -124.5% |
| Dec 2024 | N/A | N/A | -114.8% |
| Sep 2024 | N/A | N/A | -113.7% |
| Jun 2024 | N/A | N/A | -114.4% |
| Mar 2024 | 1.19 | 26.83 | 22.6% |
| Dec 2023 | 3.49 | 28.96 | 8.3% |
| Sep 2023 | 4.97 | 25.82 | 5.2% |
| Jun 2023 | 5.38 | 26.88 | 5% |
| Mar 2023 | 0.75 | 24.79 | 32.9% |
| Dec 2022 | 0.52 | 22.27 | 42.7% |
VRTX average PEG ratio chart
VRTX's PEG ratio today sits above the 3 and 10-year averages, but it is lower than the 5-year average.
PEG comparison
Vertex Pharmaceuticals's PEG of 1.39 is higher than the Healthcare sector and the industry average. Looking at the Healthcare sector average of 0.61, Vertex Pharmaceuticals's PEG is 128% higher.
VRTX EPS growth
VRTX Price vs fair value
VRTX PEG vs peers
Relative to its peer stocks ABBV and BMY, VRTX's PEG ratio is higher.
Frequently asked questions
What is Vertex Pharmaceuticals's PEG ratio?
According to Aug 21, 2026 figures, VRTX's PEG ratio stands at 1.39.
What is the 3-year average PEG ratio for Vertex Pharmaceuticals (VRTX)?
VRTX's 3-year PEG ratio average is 1.38.
What is the 5-year average PEG ratio for Vertex Pharmaceuticals (VRTX)?
VRTX's 5-year PEG ratio average is 1.42.
What is the highest PEG ratio for VRTX?
VRTX's PEG ratio topped out at 7.76 during the Mar 2018 quarter - the highest in ten years.
How does the current PEG ratio for VRTX compare to its historical average?
Compared to the 10-year average, VRTX's PEG ratio stands 12% higher.
How is VRTX's PEG ratio calculated (Vertex Pharmaceuticals PEG ratio formula)?
To calculate the PEG ratio, take the company's PE ratio and divide by its earnings per share growth (YoY TTM). As of Aug 21, 2026, Vertex Pharmaceuticals has a PE ratio of 31.62. Earnings grew at 22.7% over the TTM period ending Jun 2026. Applying the formula, this gives a PEG ratio of 1.39. PEG RATIO(1.39) = PE RATIO(31.62) / EPS GROWTH(22.7%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.